Cargando…
Accurate and objective determination of myalgic encephalomyelitis/chronic fatigue syndrome disease severity with a wearable sensor
BACKGROUND: Approximately 2.5 million people in the U.S. suffer from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This disease negatively impacts patients’ ability to function, often resulting in difficulty maintaining employment, sustaining financial independence, engaging socially...
Autores principales: | Palombo, Turner, Campos, Andrea, Vernon, Suzanne D., Roundy, Shad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653873/ https://www.ncbi.nlm.nih.gov/pubmed/33168001 http://dx.doi.org/10.1186/s12967-020-02583-7 |
Ejemplares similares
-
Experiences of Living with Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Strassheim, Victoria, et al.
Publicado: (2021) -
Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: de Vega, Wilfred C., et al.
Publicado: (2017) -
Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Che, Xiaoyu, et al.
Publicado: (2022) -
Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Montoya, Jose G., et al.
Publicado: (2021) -
Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome
por: Uhde, Melanie, et al.
Publicado: (2019)